Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution

OBJECTIVE: The aim of this study was to evaluate the efficacy, cardiotoxicity profile and long-term benefits of neoadjuvant therapy in human epidermal growth factor receptor 2-positive operable breast cancer patients. PATIENTS AND METHODS: A total of 142 patients diagnosed from 2005 to 2016 were inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Antolín, Silvia, Acea, Benigno, Albaina, Luis, Concha, Ángel, Santiago, Paz, García-Caballero, Tomás, Mosquera, Joaquín J, Varela, José Ramón, Soler, Rafaela, Calvo, Lourdes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311333/
https://www.ncbi.nlm.nih.gov/pubmed/30643452
http://dx.doi.org/10.2147/BCTT.S179750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311333/
https://www.ncbi.nlm.nih.gov/pubmed/30643452
http://dx.doi.org/10.2147/BCTT.S179750

Ejemplares similares